MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Bio-Rad Laboratories Operating Expenses 2011-2026 | BIO
Annual Operating Expenses Bio-Rad Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.03 B | 1.03 B | 1.06 B | 1.02 B | 955 M | 1.03 B | 1.01 B | 897 M | 883 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.06 B | 883 M | 991 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
47.1 M | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
301 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 13.75 | 1.18 % | $ 389 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 8.13 | -1.57 % | $ 1.22 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.13 | 0.89 % | $ 19.1 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
249 M | $ 1.41 | -4.73 % | $ 31.1 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 78.38 | 1.57 % | $ 4.28 B |  Britain |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.41 | -2.72 % | $ 25.5 M | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.43 | -6.54 % | $ 58.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 18.46 | -0.16 % | $ 433 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 11.19 | -4.28 % | $ 401 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
344 M | $ 9.73 | -1.42 % | $ 385 M |  Curacao |
 |
LENSAR
LNSR
|
32.6 M | $ 5.68 | -0.18 % | $ 67.9 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
40.3 M | $ 37.18 | 2.17 % | $ 314 M | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 3.64 | -1.89 % | $ 538 M | USA |
 |
Butterfly Network
BFLY
|
132 M | $ 5.39 | 5.07 % | $ 1.33 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 1.54 | 16.67 % | $ 64.5 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
887 M | $ 80.86 | -2.01 % | $ 10.9 B | USA |
 |
Insulet Corporation
PODD
|
531 M | $ 150.71 | -5.58 % | $ 10.6 B | USA |
 |
Profound Medical Corp.
PROF
|
52.6 M | $ 6.71 | -1.61 % | $ 203 M | Canada |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.3 | -1.63 % | $ 1.13 B | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 42.28 | 0.17 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 91.37 | -2.9 % | $ 3.17 B | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 85.98 | -1.78 % | $ 50.3 B | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.07 | -2.13 % | $ 5.74 M | USA |